rs782137551

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The variant NM_000252.3:c.1454C>T in MTM1 is a missense variant predicted to cause substitution of alanine by valine at amino acid 485 (p.Ala485Val). The filtering allele frequency in gnomAD v4.1.0 is 0.0005657 (35/45691 alleles, 10 hemizygotes) for the Admixed American population, which is higher than the ClinGen congenital myopathy MTM1 threshold (≥0.000016) for BA1, and therefore meets this criterion (BA1). The REVEL computational prediction analysis tool produced a score of 0.221, which is neither above nor below the thresholds predicting a damaging or benign impact on MTM1 function. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria met, as specified by the congenital myopathies VCEP: BA1 (ClinGen Congenital Myopathies VCEP specifications version 1; 8/7/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA10539261/MONDO:0018947/149

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 1 hem., cov: 23)
Exomes 𝑓: 0.000037 ( 0 hom. 11 hem. )

Consequence

MTM1
NM_000252.3 missense

Scores

1
1
15

Clinical Significance

Benign reviewed by expert panel B:3

Conservation

PhyloP100: -0.433

Publications

0 publications found
Variant links:
Genes affected
MTM1 (HGNC:7448): (myotubularin 1) This gene encodes a dual-specificity phosphatase that acts on both phosphotyrosine and phosphoserine. It is required for muscle cell differentiation and mutations in this gene have been identified as being responsible for X-linked myotubular myopathy. [provided by RefSeq, Jul 2008]
MTM1 Gene-Disease associations (from GenCC):
  • X-linked myotubular myopathy
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTM1NM_000252.3 linkc.1454C>T p.Ala485Val missense_variant Exon 13 of 15 ENST00000370396.7 NP_000243.1 Q13496-1A0A024RC06

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTM1ENST00000370396.7 linkc.1454C>T p.Ala485Val missense_variant Exon 13 of 15 1 NM_000252.3 ENSP00000359423.3 Q13496-1

Frequencies

GnomAD3 genomes
AF:
0.00000893
AC:
1
AN:
111926
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000950
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000192
AC:
35
AN:
182615
AF XY:
0.000119
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000985
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00177
GnomAD4 exome
AF:
0.0000375
AC:
40
AN:
1067294
Hom.:
0
Cov.:
26
AF XY:
0.0000327
AC XY:
11
AN XY:
336600
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25818
American (AMR)
AF:
0.000967
AC:
34
AN:
35162
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19179
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30069
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53445
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40411
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4026
European-Non Finnish (NFE)
AF:
0.00000491
AC:
4
AN:
814085
Other (OTH)
AF:
0.0000443
AC:
2
AN:
45099
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.427
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000893
AC:
1
AN:
111926
Hom.:
0
Cov.:
23
AF XY:
0.0000293
AC XY:
1
AN XY:
34138
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30790
American (AMR)
AF:
0.0000950
AC:
1
AN:
10529
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3588
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2723
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6009
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53201
Other (OTH)
AF:
0.00
AC:
0
AN:
1517

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000815
Hom.:
0
Bravo
AF:
0.0000529
ExAC
AF:
0.000206
AC:
25

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:1
Feb 17, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Severe X-linked myotubular myopathy Benign:1
Jul 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Centronuclear myopathy Benign:1
Aug 07, 2024
ClinGen Congenital Myopathies Variant Curation Expert Panel, ClinGen
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The variant NM_000252.3:c.1454C>T in MTM1 is a missense variant predicted to cause substitution of alanine by valine at amino acid 485 (p.Ala485Val). The filtering allele frequency in gnomAD v4.1.0 is 0.0005657 (35/45691 alleles, 10 hemizygotes) for the Admixed American population, which is higher than the ClinGen congenital myopathy MTM1 threshold (≥0.000016) for BA1, and therefore meets this criterion (BA1). The REVEL computational prediction analysis tool produced a score of 0.221, which is neither above nor below the thresholds predicting a damaging or benign impact on MTM1 function. In summary, the variant meets criteria to be classified as benign. ACMG/AMP criteria met, as specified by the congenital myopathies VCEP: BA1 (ClinGen Congenital Myopathies VCEP specifications version 1; 8/7/2024) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
11
DANN
Benign
0.97
DEOGEN2
Uncertain
0.70
D
FATHMM_MKL
Benign
0.039
N
LIST_S2
Benign
0.73
T
M_CAP
Pathogenic
0.59
D
MetaRNN
Benign
0.17
T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
0.69
N
PhyloP100
-0.43
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.65
N
REVEL
Benign
0.22
Sift
Benign
0.26
T
Sift4G
Benign
0.16
T
Polyphen
0.0
B
Vest4
0.17
MutPred
0.52
Gain of helix (P = 0.0696);
MVP
0.50
MPC
0.62
ClinPred
0.021
T
GERP RS
1.5
Varity_R
0.14
gMVP
0.50
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782137551; hg19: chrX-149828944; COSMIC: COSV99059540; API